139 related articles for article (PubMed ID: 36401285)
21. The m6A methylation profiles of immune cells in type 1 diabetes mellitus.
Wang Y; Xu L; Luo S; Sun X; Li J; Pang H; Zhou J; Zhou Y; Shi X; Li X; Huang G; Xie Z; Zhou Z
Front Immunol; 2022; 13():1030728. PubMed ID: 36457997
[TBL] [Abstract][Full Text] [Related]
22. m
Guo H; Wang B; Xu K; Nie L; Fu Y; Wang Z; Wang Q; Wang S; Zou X
Front Oncol; 2020; 10():553045. PubMed ID: 33134163
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive Analysis and Functional Characteristics of Differential Expression of N6-Methyladenosine Methylation Modification in the Whole Transcriptome of Rheumatoid Arthritis.
Wan L; Liu J; Huang C; Zhu Z; Wang K; Sun G; Zhu L; Hu Z
Mediators Inflamm; 2022; 2022():4766992. PubMed ID: 36330380
[TBL] [Abstract][Full Text] [Related]
24. RNA N6-methyladenosine reader IGF2BP3 promotes acute myeloid leukemia progression by controlling stabilization of EPOR mRNA.
Fan J; Zhuang M; Fan W; Hou M
PeerJ; 2023; 11():e15706. PubMed ID: 37663284
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive Analysis of m6A RNA Methylation Regulators in the Prognosis and Immune Microenvironment of Multiple Myeloma.
Liu R; Shen Y; Hu J; Wang X; Wu D; Zhai M; Bai J; He A
Front Oncol; 2021; 11():731957. PubMed ID: 34804925
[TBL] [Abstract][Full Text] [Related]
26. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
[TBL] [Abstract][Full Text] [Related]
27. m6A RNA methylation regulators were associated with the malignancy and prognosis of ovarian cancer.
Zhang C; Liu J; Guo H; Hong D; Ji J; Zhang Q; Guan Q; Ren Q
Bioengineered; 2021 Dec; 12(1):3159-3176. PubMed ID: 34187307
[TBL] [Abstract][Full Text] [Related]
28. Knockdown RBM15 Inhibits Colorectal Cancer Cell Proliferation and Metastasis Via N6-Methyladenosine (m6A) Modification of MyD88 mRNA.
Zhang Z; Mei Y; Hou M
Cancer Biother Radiopharm; 2022 Dec; 37(10):976-986. PubMed ID: 34842457
[TBL] [Abstract][Full Text] [Related]
29. Activation of the HNRNPA2B1/
Sun M; Shen Y; Jia G; Deng Z; Shi F; Jing Y; Xia S
J Cancer; 2023; 14(7):1242-1256. PubMed ID: 37215455
[TBL] [Abstract][Full Text] [Related]
30. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.
Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G
J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207
[TBL] [Abstract][Full Text] [Related]
31. Four m6A RNA Methylation Gene Signatures and Their Prognostic Values in Lung Adenocarcinoma.
Wang Y; Zhao X; Li J; Wang X; Hu W; Zhang X
Technol Cancer Res Treat; 2022; 21():15330338221085373. PubMed ID: 35343834
[No Abstract] [Full Text] [Related]
32. Splicing factor hnRNPA2B1 contributes to tumorigenic potential of breast cancer cells through STAT3 and ERK1/2 signaling pathway.
Hu Y; Sun Z; Deng J; Hu B; Yan W; Wei H; Jiang J
Tumour Biol; 2017 Mar; 39(3):1010428317694318. PubMed ID: 28351333
[TBL] [Abstract][Full Text] [Related]
33. RNA m6A demethylase FTO-mediated epigenetic up-regulation of LINC00022 promotes tumorigenesis in esophageal squamous cell carcinoma.
Cui Y; Zhang C; Ma S; Li Z; Wang W; Li Y; Ma Y; Fang J; Wang Y; Cao W; Guan F
J Exp Clin Cancer Res; 2021 Sep; 40(1):294. PubMed ID: 34544449
[TBL] [Abstract][Full Text] [Related]
34. HNRNPA2B1 Affects the Prognosis of Esophageal Cancer by Regulating the miR-17-92 Cluster.
Li K; Chen J; Lou X; Li Y; Qian B; Xu D; Wu Y; Ma S; Zhang D; Cui W
Front Cell Dev Biol; 2021; 9():658642. PubMed ID: 34277606
[TBL] [Abstract][Full Text] [Related]
35. hnRNPA2B1 Promotes Colon Cancer Progression via the MAPK Pathway.
Tang J; Chen Z; Wang Q; Hao W; Gao WQ; Xu H
Front Genet; 2021; 12():666451. PubMed ID: 34630502
[TBL] [Abstract][Full Text] [Related]
36. Construction of a risk prediction model using m6A RNA methylation regulators in prostate cancer: comprehensive bioinformatic analysis and histological validation.
Quan Y; Zhang X; Ping H
Cancer Cell Int; 2022 Jan; 22(1):33. PubMed ID: 35045837
[TBL] [Abstract][Full Text] [Related]
37. RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent.
Wang X; Tian L; Li Y; Wang J; Yan B; Yang L; Li Q; Zhao R; Liu M; Wang P; Sun Y
J Exp Clin Cancer Res; 2021 Feb; 40(1):80. PubMed ID: 33637103
[TBL] [Abstract][Full Text] [Related]
38. N6-methyladenosine modification of TGM2 mRNA contributes to the inhibitory activity of sarsasapogenin in rheumatoid arthritis fibroblast-like synoviocytes.
Lin X; Tao C; Zhang R; Zhang M; Wang Q; Chen J
Phytomedicine; 2022 Jan; 95():153871. PubMed ID: 34902811
[TBL] [Abstract][Full Text] [Related]
39. Correction: HNRNPA2B1-mediated m6A modification of TLR4 mRNA promotes progression of multiple myeloma.
Jia C; Guo Y; Chen Y; Wang X; Xu Q; Zhang Y; Quan L
J Transl Med; 2023 Jan; 21(1):58. PubMed ID: 36717915
[No Abstract] [Full Text] [Related]
40. RNA m6A Methylation Regulators Multi-Omics Analysis in Prostate Cancer.
Su H; Wang Y; Li H
Front Genet; 2021; 12():768041. PubMed ID: 34899855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
